Literature DB >> 25331545

The effectiveness of helplines for the treatment of alcohol and illicit substance use.

Peter Gates1.   

Abstract

While tobacco helplines (quitlines) are thought to be effective, helplines which treat other substance use do not have an established evidence base. A review was conducted of the literature on illicit drug or alcohol (IDA) helplines. The literature search was conducted in five databases. Studies prior to 2014 were included if published in English, and involved the use of a telephone counselling helpline for the treatment of illicit drug or alcohol use. Review papers, opinion pieces, letters or editorials, case studies, published abstracts and posters were excluded. Initial searching identified 2178 articles and after removing duplicates and those meeting the exclusion criteria, there were 36 publications for review. A total of 29 articles provided descriptive information about 19 different IDA helplines which operated in the US (42%), Europe (21%), Australia (21%), Asia (11%) and Canada (5%). These services reported monthly call rates from 3.7 to over 23,000 calls per month. A total of nine articles provided evaluative information on eight different IDA helplines: four articles included a comparison of treatment outcomes against a control group and five articles included information on treatment satisfaction or service utilisation. Together they provide some evidence that these services are effective. Although there was little consistency in the measures used between articles which assessed helpline satisfaction, all but one reported high satisfaction. Although the evidence is mainly supportive of IDA helplines, further work is required to compare treatment outcomes in randomized groups.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Mesh:

Year:  2014        PMID: 25331545     DOI: 10.1177/1357633X14555643

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  6 in total

1.  Exploring the feasibility of general health promotion in UK dental primary care: ENGAGE in Scotland.

Authors:  D Bonetti; L Young; L Hempleman; J Deas; S Shepherd; J Clarkson
Journal:  Br Dent J       Date:  2018-10-12       Impact factor: 1.626

2.  Addressing Adverse Childhood Experiences in Primary Care: Challenges and Considerations.

Authors:  Howard Dubowitz; David Finkelhor; Adam Zolotor; Jennifer Kleven; Neal Davis
Journal:  Pediatrics       Date:  2022-04-01       Impact factor: 9.703

3.  Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study.

Authors:  Sean Kristina Bristowe; Sumantra Monty Ghosh; Michael Trew; Katherine Rittenbach
Journal:  JMIR Res Protoc       Date:  2021-05-12

4.  Targeting multiple health risk behaviours among vocational education students using electronic feedback and online and telephone support: protocol for a cluster randomised trial.

Authors:  Flora Tzelepis; Christine L Paul; John Wiggers; Kypros Kypri; Billie Bonevski; Patrick McElduff; Mary Ann Hill; Philip J Morgan; Marita Lynagh; Clare E Collins; Elizabeth Campbell; Ryan J Courtney; Kathy Chapman; Luke Wolfenden; Ashleigh Guillaumier; Andrew Searles
Journal:  BMC Public Health       Date:  2015-06-13       Impact factor: 3.295

5.  Characteristics of Gamblers Who Use the French National Problem Gambling Helpline and Real-Time Chat Facility: Longitudinal Observational Study.

Authors:  Stéphane Darbeda; Henri-Jean Aubin; Michel Lejoyeux; Amandine Luquiens
Journal:  JMIR Form Res       Date:  2020-05-20

6.  1800 121 2096 Diabeteshelp - A toll free helpline for people with diabetes.

Authors:  Sridivya Mukpalkar; Clare Gilbert; G V S Murthy; Anirudh G Gudlavalleti; Tripura Batchu; Supriya Edla; Vandana Hebrew; Leela Vemulapalli; Harika Janagama; Rajan Shukla; Vidyadhar M S Bala; Pavani Yamarthi; Suneetha Pendyala; Anusha Puppala
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.